Skip to content

Merck & Company Inc Price, Chart & Factor Exposure

Free Data & Analytics Access
Merck & Company Inc · E.MRK.BA · Argentina
Use symbol E.MRK.BA in our API & Excel add-in to retrieve this data ↓
47,840.00
(+0.04%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum -50%
Trend 25%
Bubble Risk LOW
Realised Volatility (20D) 35.86%

Merck & Company Inc Forecast

Merck & Company Inc short-term momentum is negative (up over 1 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term SELL signal. The long-term trend is positive (5 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 35.9% a year, a typical one-standard-deviation range is 45,424–50,256 over a week, 42,888–52,792 over a month and 30,686–64,994 over a year. (Signals as of 21 Nov 2026.)

Merck & Company Inc Price Chart

MacroFinance.ai

Merck & Company Inc Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Merck & Company Inc
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Merck & Company Inc
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Merck & Company Inc
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for Merck & Company Inc, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on Merck & Company Inc

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Statistical Distribution of Returns

Plus

How Merck & Company Inc’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Merck & Company Inc behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Merck & Company Inc (Argentina)

Merck & Company Inc is a listed security in Argentina. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Merck & Company Inc

Frequently asked questions

What is Merck & Company Inc?
Merck & Company Inc is a listed security in Argentina. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns and free historical data.
What is the latest Merck & Company Inc price?
The latest close is 47,840 (21 Nov 2026), +0.04% on the day. The price at the top of the page refreshes during the trading day.
Is Merck & Company Inc in an uptrend?
As of 21 Nov 2026, short-term momentum is negative (1 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is positive (5 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Merck & Company Inc?
20-day realised volatility is 35.9% a year (21 Nov 2026), which implies a typical one-standard-deviation move of about 10.4% over a month and 5.1% over a week.
What factors affect Merck & Company Inc?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Merck & Company Inc, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
How are Merck & Company Inc returns analysed?
The Statistical Distribution of Returns section shows the distribution of Merck & Company Inc daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Merck & Company Inc historical data?
In the Free historical data section of this page: the last 10 years of Merck & Company Inc daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Merck & Company Inc historical data (last 10 years)

Browse or instantly download the last 10 years of Merck & Company Inc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.MRK.BA&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-2047840
2026-11-1946100
2026-11-1847320
2026-11-1748520
2026-11-1648500
2026-11-1349500
2026-11-1249200
2026-11-1149360
2026-11-1048760
2026-11-0648760
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.